Lorenzo Triana
Psychiatry · Plano, TXNPI 1699700955
Payments from drug & device makers
Across 282 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$1K
- AbbVie$676
- Otsuka America Pharmaceutical, Inc.$549
- Corium, LLC$543
- Takeda Pharmaceuticals U.S.A., Inc.$517
- Johnson & Johnson$378
- plus $1K from 18 others
What the payments were for
- Food & beverage$5,324100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 62 | $1,166 |
| AbbVie(2 entities) | 35 | $676 |
| Otsuka America Pharmaceutical, Inc. | 30 | $549 |
| Corium, LLC | 24 | $543 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $517 |
| Johnson & Johnson | 22 | $378 |
| Neos Therapeutics, LP | 21 | $349 |
| Supernus Pharmaceuticals, Inc. | 9 | $174 |
| Bausch Health US, LLC | 9 | $167 |
| Sunovion Pharmaceuticals Inc. | 6 | $117 |
| Adlon Therapeutics L.p. | 6 | $103 |
| Axsome Therapeutics, Inc. | 4 | $88 |
| Shire North American Group Inc | 4 | $77 |
| Jazz Pharmaceuticals Inc. | 3 | $60 |
| Noven Therapeutics, LLC | 3 | $56 |
| Sandoz | 1 | $50 |
| Idorsia Pharmaceuticals US Inc | 2 | $44 |
| Ironshore Pharmaceuticals Inc. | 1 | $43 |
| Tris Pharma Inc | 2 | $39 |
| Almatica Pharma LLC | 2 | $38 |
| Neuronetics, Inc. | 2 | $34 |
| Avion Pharmaceuticals | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Alkermes, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$120
How this compares
$5,326 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 13 | $6,272 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,116 |
| Bupropion XlBupropion Hcl | 73 | $2,874 |
| Escitalopram Oxalate | 79 | $1,302 |
| Trazodone Hcl | 94 | $1,057 |
| Duloxetine Hcl | 23 | $948 |
| Sertraline Hcl | 107 | $940 |
| Doxepin Hcl | 19 | $817 |
| Atomoxetine Hcl | 11 | $765 |
| Clonazepam | 51 | $721 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 21 | $678 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $570 |
| Buspirone Hcl | 38 | $548 |
| Quetiapine Fumarate | 16 | $266 |
| Lamotrigine | 12 | $222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $517 | $10,38824 claims |
| Almatica Pharma LLCSertraline Hcl | $38 | $940107 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Plano
- Suresh SureddiPlano$5.9M
- Sejal MehtaPlano$3.3M
- David CrumpackerPlano$386K
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.